Changjiang Runfa Medicine Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Changjiang Runfa Medicine Co Ltd with three other
companies in this sector in China:
Shenzhen Hepalink Pharmaceutical Company Limited
sales of 2.26 billion Chinese Renmimbi [US$351.17 million]
of which 100%
was Pharmaceutical Manufacturing),
Zhejiang Jingxin Pharmaceutical Co., Ltd.
(1.87 billion Chinese Renmimbi [US$291.38 million]
of which 57%
was Pharmaceutical Ingredient), and
PKU HealthCare Corp Ltd
(2.07 billion Chinese Renmimbi [US$321.71 million]
of which 86%
was Merchandise&Material Selling).
During the year ended December of 2016, sales at
Changjiang Runfa Medicine Co Ltd were 2.11 billion Chinese Renmimbi (US$328.71 million).
increase of 98.6%
versus 2015, when the company's sales were 1.06 billion Chinese Renmimbi.